-
2019.03
REGEND001 clinical trial application accepted by the National Mecical Products Adminstration
-
2019.01
Prof. Zuo was elected as one of the top ten innovative figures of People's Pictorial in 2018
-
2019.01
Regend 's Project was elected as the top ten advances in Chinese medical biotechnology in 2018
-
2018.07
Jiangxi Xlotus Medical Science and Technology Co., Ltd is located in Nanchang
-
2018.06
Comrade Zhang Hepingmet with Zuo Wei and his delegation of Regend
-
2018.05
Regend won the support of the National Key R&D Program
-
2018.02
CCTV reports that a team with Prof. Zuo as its core has achieved human lung regeneration
-
2017.08
Jiangnan Stem Cell Research Institute in Zhejiang Province establishmen
-
2017.06
Supported by the National Key R&D Program of "Stem Cell and Transformation Research" in 2017
-
2017.02
Complete Round A Financing
-
2016.12
The First Batch of Stem Cell Clinical Recording Enterprises of National Health Commission
-
2016.11
People's reported the innovative results of Gimeresen stem cell therapy
-
2016.08
Hangzhou GMP-level R&D and production base has been completed and put into use
-
2016.04
GMP-level R&D and production bases in Shanghai and Suzhou have been established
-
2016.04
Chairman Zuo Wei was awarded the Scholars of the Changjiang River Award Scheme
-
2015.12
Prof. Zuo Wei was selected as the 12th batch of experts in the National Youth Thousand Program
-
2015.10
2015 National Natural Science Foundation of China Project
-
2015.09
Prof. Zuo Wei was selected as a leading talents of Tongji University in 2015
-
2015.08
Complete angel financing
2015.07
Company establishmen